For research use only. Not for therapeutic Use.
Sonelokimab（Cat No.:I042199）is a monoclonal antibody that targets IL-17A, a pro-inflammatory cytokine involved in various autoimmune diseases. By inhibiting IL-17A, sonelokimab aims to reduce inflammation and tissue damage associated with conditions like psoriasis, rheumatoid arthritis, and ankylosing spondylitis. It is designed to block the signaling pathway that contributes to the inflammatory response in these disorders. Currently in clinical trials, sonelokimab is being evaluated for its safety, efficacy, and potential to improve symptoms in patients with inflammatory diseases, particularly those unresponsive to other treatments.
| Catalog Number | I042199 |
| CAS Number | 1414386-05-2 |
| Purity | ≥95% |
